Sep 10, 2026 · 31 min · 10 segments
In this episode of NETCast, we explore two increasingly important, and often underrecognized, aspects of neuroendocrine tumor care: hereditary risk assessment and long-term systemic complications…
Daniel HalperinHost
Pamela BrockGuestA.J. VallicottiGuestAnd much more.
I'm Dr. Daniel Halpern, and today we are discussing two incredibly important and often under-recognized aspects of neuroendocrine tumor patient care, hereditary risk assessment and long-term systemic complications, including carcinoid heart disease.
As patients with NETs are living longer and care becomes increasingly personalized, larger and larger multidisciplinary teams are expanding beyond traditional oncology models.
Today's discussion will focus on how genetics, cardiology, survivorship, and coordinated specialty care are becoming increasingly important in comprehensive neuroendocrine tumor patient management.
I'm joined today by Pamela Brock and Dr. A.J. Vallicotti, and we'll be exploring how multidisciplinary collaboration can help improve care across the full continuum of the patient journey.
Before we jump into what I expect to be a lively and really fun discussion, let's go around with a quick round of introductions where you can introduce yourselves, your specialty, and one area within NetCare that you think multidisciplinary collaboration has really become increasingly important.
Read the full transcript.
Create an account to read the whole episode, search across every transcript, and follow the shows you care about.